An Australian stem cell and regenerative medicine company

November 02, 2022

New trial using stem cells to stop kidney transplant rejection

Expected to commence next year, Cynata along with leading transplant centre Leiden University Medical Center (LUMC) in the Netherlands, will collaborate on a new clinical trial in patients who have received a kidney transplant. The trial will investigate Cynata’s MSCs as a treatment for renal graft rejection and to potentially reduce the requirement for anti-rejection drugs.

Read More Here (scroll midway)